PI(4)K Inhibitor Could Prove Cure For Killer Diarrhoea

News   Jun 06, 2017 | Original Story from Novartis

 
A Cryptosporidium PI(4)K Inhibitor is a Drug Candidate for Cryptosporidiosis

Cryptosporidium parvum. Credit: EPA/H.D.A. Lindquist

 
 
 

RELATED ARTICLES

Patent Plausability Case Sees BIA Intervention

News

The UK Bioindustry Association (BIA) will intervene in a court case which could have huge ramifications for UK bioscience.

READ MORE

Microwaves Could be as Bad for the Environment as Cars

News

Microwaves usage across the EU alone emits as much carbon dioxide as nearly seven million cars according to a new study. Researchers have carried out the first ever comprehensive study of the environmental impacts of microwaves, considering their whole life cycle, from ‘cradle to grave’.

READ MORE

Study Reveals How MRSA Infection Compromises Lymphatic Function

News

Infections of the skin or other soft tissues with the hard-to-treat MRSA bacteria appear to permanently compromise the lymphatic system, which is crucial to immune system function. Investigators describe how MRSA infection impairs the ability of lymphatic vessels to pump lymphatic fluid to lymph nodes in mouse models, which may contribute to the frequent recurrences of MRSA infection experienced by patients.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE